Bacaling, Arabella .
HRN: 24-37-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2024
CEFTRIAXONE 1G (VIAL)
01/06/2024
01/13/2024
IV
2g
OD
Typhoid Fever
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes